Index to Posts on Pharming [Added 1H08 results and musings on a GTC-Pharming merger.] <a href='read_msg.asp?message_id=30035067'>#msg-30035067</a> Phase-3 Rhucin data (US) <a href='read_msg.asp?message_id=22482530'>#msg-22482530</a> Pharming seeks US Rhucin partner <a href='read_msg.asp?message_id=22208171'>#msg-22208171</a> Phase-3 Rhucin data (Europe) <a href='read_msg.asp?message_id=27808107'>#msg-27808107</a> EMEA rejects Rhucin re-examination #msg- 30621194 Rhucin open-label extension studies <a href='read_msg.asp?message_id=30791875'>#msg-30791875</a> 1H08 financial results <a href='read_msg.asp?message_id=28546713'>#msg-28546713</a> Update from 2008 annual meeting <a href='read_msg.asp?message_id=28738755'>#msg-28738755</a> New program in “aging” <a href='read_msg.asp?message_id=30659059'>#msg-30659059</a> Musings on a GTC-Pharming merger <a href='read_msg.asp?message_id=18949245'>#msg-18949245</a> IP cross-license with GTC <a href='read_msg.asp?message_id=27220955'>#msg-27220955</a> Pharming licenses cattle IP from ACTC <!--Beg_Sig--> <a href=http://www.investorshub.com/boards/board.asp?board_id=1418>Let’s talk biotech!</a> “The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”